PLA General Hospital
Beijing, Beijing Municipality, 100071, China
NCT Number: NCT03776916
This is a randomized controlled trial to comparing the different simethicone administration strategies for esophagogastroscopy. Recent studies have indicated that the administration of simethicone before endoscopic examination could shorten the procedure time and improve the diagnostic rate of the gastric mucosal lesions. But the time interval between simethicone administration and the examination has not been fully determined. This study will test whether the time of taking simethicone before endoscopy could influence the performance of the procedure in a randomized controlled trial. The results may benefit the current clinical practice.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Beijing, Beijing Municipality, 100071, China
Esophagogastroscopy can enable the direct examination of the esophageal and gastric mucosal lesions, which has been widely applied in clinical practice. However, during the examination, too much water, foam or residues in the stomach will not only increase the procedure time and the misdiagnosis rate, but also decrease the patients' tolerance, for more efforts should be made to deal with the excessive water, foam or residues in order to obtain a clear view of the mucosa. Simethicone is also called poly-dimethylsiloxane, which can be used to remove the foam and water. Although simethicone has been routinely administrated before the esophagogastroscopy, the optimal strategy of administrating simethicone has not been clearly investigated, especially the time to administrate simethicone. Intaking simethicone too early will result in too excessive water in the stomach, while if the patients take it too late it doesn't take effects. Thus, this is a study to determine whether selecting different simethicone administration strategies could improve the performance of the esophagogastroscopy and minimize the patients' dissatisfaction.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Patients intake simethicone 20-30 min before the procedure
Patients intake simethicone administration 31-60 min before the procedure.
Patients intake simethicone administration > 60 min before the procedure.
Time frame: 4 months
The time of examining the whole stomach was recorded, and the time for biopsy was not included.
Time frame: 4 months
A 10-point scale was used to evaluate the patients' satisfaction (0 worst, 10 best). All the symptoms such as abdominal pain, distension and the like were all recorded.
It is anticipated that the use of simethicone will significantly improve patients' satisfaction.
Affiliated Hospital to Academy of Military Medical Sciences
Other
Optimization of Simethicone Administration Strategy Before Esophagogastroscopy
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06958250
Digestive System Diseases, Gastric Disease
Plainsboro, New Jersey, United States
View Trial DetailsNCT05392452
Artificial Pancreas, Closed-Loop Glucose Control
Basel, Switzerland
View Trial DetailsNCT04479423
Capsule Endoscopy, Digestive System Diseases
Shanghai, Shanghai Municipality, China
View Trial DetailsNCT03198871
Abdominal Wall Hernia, Bowel Disease
Pittsburgh, Pennsylvania, United States
View Trial Details